Drug Approved for Rare Mutation in Gastrointestinal Tumor

The FDA has approved a tyrosine kinase inhibitor to treat adults with an unresectable or metastatic gastrointestinal stromal tumor (GIST) that has a specific genetic mutation.
Source: JAMA - Category: General Medicine Source Type: research